ARKG240802C19000
- 6.60
- 0.000.00%
ARK Genomic Revolution ETF Newsroom
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
Serve Robotics Stock Continues To Soar 26% Friday: What's Going On?
IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday
Actinium Wins FDA Nod to Conduct Clinical Trial for Radiotherapy
Tesla Bull Cathie Wood's Ark Invest Sells $7.16M Worth Of EV Maker's Shares After Q2 Earnings Reveal Profits Tanked Sharply
Leerink Upgrades Ionis to Outperform, Cites Angelman Drug
Beam Therapeutics Gains as H.C. Wainwright Starts at Buy
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Beam Therapeutics Analyst Ratings
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
Where CareDx Stands With Analysts
CareDx Analyst Ratings
The Latest Analyst Ratings For Ionis Pharmaceuticals
12 Analysts Assess 10x Genomics: What You Need To Know
Ionis Pharmaceuticals Analyst Ratings
Beam Therapeutics Has Initiated A Search For A New CFO After Terry-Ann Burrell Shared Plans To Depart On August 9 To Join JPMorgan Chase
These Are the Stocks With the Highest Increase in Short Interest Within Life Sciences and Diagnostics - Baird
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
What Analysts Are Saying About Schrodinger Stock